In this study, we carried out a meta-analysis focusing on the relationship between length of poly-Q repeat domain as a modifier of BC susceptibility in patients with BRCA1/2 mutation carriers to provide a basis for more evidence-based counselling and decision making. The gene discussed is BRCA1; the disease is breast cancer.